000 01801 a2200481 4500
005 20250513115622.0
264 0 _c19970529
008 199705s 0 0 eng d
022 _a0020-7136
024 7 _a10.1002/(sici)1097-0215(19970502)71:3<429::aid-ijc21>3.0.co;2-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMattes, M J
245 0 0 _aThe advantage of residualizing radiolabels for targeting B-cell lymphomas with a radiolabeled anti-CD22 monoclonal antibody.
_h[electronic resource]
260 _bInternational journal of cancer
_cMay 1997
300 _a429-35 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xpharmacokinetics
650 0 4 _aAntigens, CD
_ximmunology
650 0 4 _aAntigens, Differentiation, B-Lymphocyte
_ximmunology
650 0 4 _aCell Adhesion Molecules
_ximmunology
650 0 4 _aHumans
650 0 4 _aIndium Radioisotopes
_xpharmacokinetics
650 0 4 _aIodine Radioisotopes
_xpharmacokinetics
650 0 4 _aLectins
650 0 4 _aMetabolic Clearance Rate
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aPentetic Acid
_xpharmacokinetics
650 0 4 _aRadioimmunodetection
_xmethods
650 0 4 _aSialic Acid Binding Ig-like Lectin 2
650 0 4 _aTime Factors
650 0 4 _aTransplantation, Heterologous
650 0 4 _aTumor Cells, Cultured
700 1 _aShih, L B
700 1 _aGovindan, S V
700 1 _aSharkey, R M
700 1 _aOng, G L
700 1 _aXuan, H
700 1 _aGoldenberg, D M
773 0 _tInternational journal of cancer
_gvol. 71
_gno. 3
_gp. 429-35
856 4 0 _uhttps://doi.org/10.1002/(sici)1097-0215(19970502)71:3<429::aid-ijc21>3.0.co;2-9
_zAvailable from publisher's website
999 _c9121301
_d9121301